Active Ingredient History
Tegafur is a chemotherapeutic prodrug of 5-fluorouracil (5-FU) used in the treatment of cancers. It is a component of the combination drug tegafur/uracil. When metabolised, it becomes 5-FU. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma (Phase 3)
Aged (Phase 2)
Anterior Cruciate Ligament Injuries (Phase 2)
Bacterial Infections (Phase 4)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 3)
Breast Neoplasms (Phase 4)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cetuximab (Phase 2)
Chemoradiotherapy (Phase 3)
Chemoradiotherapy, Adjuvant (Phase 2)
Chemotherapy, Adjuvant (Phase 3)
Cholangiocarcinoma (Phase 3)
Colonic Neoplasms (Phase 4)
Colorectal Neoplasms (Phase 3)
Digestive System Neoplasms (Phase 1)
Drugs, Investigational (Phase 2)
Drug Therapy (Phase 2/Phase 3)
Endothelium (Phase 2)
Esophageal Diseases (Phase 2)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Esophagogastric Junction (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrectomy (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
General Surgery (Phase 2/Phase 3)
Head and Neck Neoplasms (Phase 3)
Helicobacter pylori (Phase 4)
Immune System Diseases (Phase 2)
Immunotherapy (Phase 2/Phase 3)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 2)
Lung Neoplasms (Phase 3)
Maintenance Chemotherapy (Phase 2)
Malaria (Phase 3)
Melanoma (Phase 1/Phase 2)
Microsatellite Instability (Phase 4)
Nasopharyngeal Carcinoma (Phase 2)
Neoadjuvant Therapy (Phase 4)
Neoplasm Metastasis (Phase 3)
Neoplasms ()
Neuroendocrine Tumors (Phase 1/Phase 2)
Oropharyngeal Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 3)
Oxaliplatin (Phase 2)
Pancreatic Neoplasms (Phase 4)
Peritoneal Neoplasms (Phase 2)
Progression-Free Survival (Phase 2)
Radiotherapy (Phase 2/Phase 3)
Radiotherapy, Intensity-Modulated (Phase 2)
Rectal Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 4)
Tuberculosis (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue